{"id":11233,"date":"2024-05-30T13:32:04","date_gmt":"2024-05-30T17:32:04","guid":{"rendered":"https:\/\/www.med.unc.edu\/urology\/?p=11233"},"modified":"2024-05-30T13:32:04","modified_gmt":"2024-05-30T17:32:04","slug":"nielsen-selected-for-national-academy-of-medicine-nam-scholars-in-diagnostic-excellence-program","status":"publish","type":"post","link":"https:\/\/www.med.unc.edu\/urology\/nielsen-selected-for-national-academy-of-medicine-nam-scholars-in-diagnostic-excellence-program\/","title":{"rendered":"Nielsen Selected for National Academy of Medicine (NAM) Scholars in Diagnostic Excellence Program"},"content":{"rendered":"
ºÚÁÏÍø Urology is proud to announce the selection of Dr. Matthew Nielsen<\/a>, Professor and Chair of Urology and Member of the ºÚÁÏÍø Lineberger Comprehensive Cancer Center, for the National Academy of Medicine (NAM) Scholars in Diagnostic Excellence Program<\/a>.<\/p>\n The NAM Scholars program, funded by the Gordon and Betty Moore Foundation in collaboration with the Council of Medical Specialty Societies, seeks to cultivate a cadre of leaders equipped to drive implementation of effective diagnostic strategies.<\/p>\n Dr. Nielsen’s submitted proposal for the program focuses on the steps downstream from a PSA screening test. His proposed effort would leverage innovative programs optimizing the quality of prostate MRI<\/a>, in partnership with radiologists, and novel MRI-targeted \u201cfusion\u201d biopsy, building on the ºÚÁÏÍø\u2019s participation in nationally recognized improvement collaboratives<\/a> in the space.<\/p>\n By combining these approaches at scale, the proposal would form a systematic strategy to improve quality and address historical disparities in the early detection of prostate cancer, as an initial step towards the goal of advancing Diagnostic Excellence across a broader range of conditions.<\/p>\n<\/div>\n